4CYTE for Dogs — What It Does, How to Give It, Dosing & Side Effects

4CYTE is a joint health supplement for dogs developed around a patented, globally exclusive ingredient called Epiitalis® — a proprietary plant seed oil extract derived from the seeds of the plant Biota orientalis. Unlike most joint supplements that rely primarily on glucosamine and chondroitin, 4CYTE uses Epiitalis® as its core active ingredient, combined with marine-derived compounds including green-lipped mussel, abalone, and marine cartilage. It comes in two forms — granules mixed into food and a liquid gel applied orally — and is distributed in the United States by Interpath USA Inc, based in Great Neck, New York. The product is backed by peer-reviewed clinical research published in veterinary journals, including a randomized controlled trial conducted at the University of Melbourne. Here is what every dog owner should know before giving it.

• 1
  What does 4CYTE do for dogs? Four primary actions: (1) supports cartilage cell regeneration by stimulating chondrocytes — the cells that build and maintain joint cartilage · (2) reduces inflammatory compounds that drive joint pain · (3) maintains healthy joint function, flexibility, and mobility · (4) supports connective tissue health and slows progression of osteoarthritis over time

  4CYTE works differently from most joint supplements on the market because its core ingredient, Epiitalis®, has a demonstrated ability to stimulate chondrocyte proliferation — meaning it supports the regeneration of the cells responsible for building and maintaining cartilage. Most conventional joint supplements (glucosamine, chondroitin) primarily provide building blocks for cartilage maintenance; Epiitalis® is patented specifically for its ability to stimulate cartilage cell growth even in the presence of active inflammation, which is the most clinically significant challenge in osteoarthritis management. In addition to its cartilage-support action, Epiitalis® reduces the inflammatory pathway compounds that cause joint pain at the source — so rather than simply masking pain (as NSAIDs do), it targets both the structural deterioration and the inflammatory response driving discomfort. The marine ingredients in the formula (green-lipped mussel, abalone, marine cartilage) contribute Omega-3 fatty acids and naturally occurring compounds that further support the anti-inflammatory and joint-rebuilding effects. Together, the formula is designed not just to reduce pain today, but to slow the underlying joint deterioration that makes osteoarthritis progressively worse over time.
• 2
  What do vets say about 4CYTE? Generally positive — 4CYTE is one of the few dog joint supplements with peer-reviewed clinical trial evidence · Recommended for senior dogs (7+), large breeds prone to arthritis, post-surgical joint recovery, and working dogs · Vets particularly value: (1) no gastrointestinal or kidney risks of long-term NSAIDs, (2) can be used alongside prescription medications, (3) demonstrable clinical research rather than marketing claims alone

  The veterinary community’s reception of 4CYTE is more favorable than for most over-the-counter joint supplements — primarily because the product has a published, peer-reviewed clinical trial behind it rather than relying entirely on anecdotal customer reviews and manufacturer claims. The University of Melbourne conducted a randomized, masked, controlled trial comparing 4CYTE Canine Granules to carprofen (a commonly prescribed NSAID for canine osteoarthritis) in 66 dogs with naturally occurring osteoarthritis. The study found that 4CYTE Canine Granules performed at a level statistically non-inferior to carprofen at Day 14 (owner mobility score) and non-inferior by all three assessment measures at Day 28 — meaning it performed comparably to a prescription-strength anti-inflammatory over 28 days. Veterinarians particularly note two clinically useful properties: 4CYTE can be safely combined with prescription anti-inflammatory medications for dogs with moderate-to-severe arthritis, and it carries none of the gastrointestinal, kidney, or liver risks associated with long-term NSAID use. This makes it well-suited as either a first-line option for mild-to-moderate joint disease or as a supportive addition to prescription treatment for more advanced cases. Most veterinarians recommend 4CYTE for senior dogs aged 7 and older as a proactive joint maintenance supplement, even before visible symptoms appear.
• 3
  Is 4CYTE anti-inflammatory? Yes — Epiitalis® reduces the inflammatory compounds associated with joint disease · It is not a non-steroidal anti-inflammatory drug (NSAID) — it has no gastrointestinal, kidney, or liver risks associated with NSAIDs · The green-lipped mussel component also provides natural Omega-3s with additional anti-inflammatory properties · Anti-inflammatory effect is gentler and cumulative, not immediate like prescription NSAIDs

  4CYTE does have genuine anti-inflammatory properties — but it works through a completely different mechanism than prescription NSAIDs like carprofen, meloxicam, or deracoxib. NSAIDs block the COX enzyme pathway to reduce inflammation and pain, typically producing noticeable relief within hours to days. Epiitalis® addresses inflammatory pathways associated with cartilage degradation and joint disease — a more targeted, slower-acting anti-inflammatory effect that takes weeks to reach full effect. Green-lipped mussel (Perna canaliculus), one of the marine ingredients in 4CYTE Canine granules, contains eicosatetraenoic acid (ETA), a unique Omega-3 fatty acid with documented anti-inflammatory properties in canine joints — distinct from the EPA and DHA found in standard fish oil. Together, these ingredients create a multi-layered anti-inflammatory effect that addresses both the pain and the underlying joint deterioration, but does so gradually. This is why 4CYTE requires a loading dose phase before dropping to maintenance dosing — the ingredients build in the system over 4–6 weeks to reach therapeutic levels. It is not a replacement for NSAIDs in dogs with acute pain or severe arthritis that requires rapid symptom relief.
• 4
  How often should I give 4CYTE to my dog? Once daily — every day · Two-phase dosing: Loading Phase (first 4–6 weeks): higher dose to build therapeutic levels · Maintenance Phase (ongoing): reduced dose, typically half the loading amount · Introduce gradually for the first 3 days at half the loading dose to allow the digestive system to adjust · Mix into food (granules) or administer orally (gel)

  4CYTE is given once daily, every day, year-round. The dosing protocol follows a two-phase approach that is distinct from most supplements and is important to follow correctly to achieve good results. During the Loading Phase (first 4–6 weeks), a higher daily dose is given to build Epiitalis® to effective therapeutic concentrations in the body’s tissues. During the Maintenance Phase (after the loading period), the daily dose is reduced — typically by half — and continued indefinitely for ongoing joint support. Before starting the loading dose, it is recommended to introduce 4CYTE at half the loading dose for the first three days to give your dog’s digestive system time to adjust to the new ingredients, particularly the marine-derived compounds. The granule form is mixed directly into your dog’s food — most dogs accept it willingly due to its palatable chicken flavor (the inactive ingredients include honey, molasses powder, nature-identical chicken flavor, and sodium caseinate). The liquid gel form is administered orally using the supplied syringe applicator. The gel is shaken well before each use to prevent separation of ingredients. Consistent daily administration — rather than occasional or as-needed dosing — is essential for maintaining the therapeutic cartilage and anti-inflammatory effects of Epiitalis®.
• 5
  How long does it take for 4CYTE to work in dogs? Some dogs show improvement in as little as 7–14 days · Most owners see clear results within 4 weeks (by the end of the loading phase) · The University of Melbourne pilot study found 93.5% of dogs showed owner-reported quality-of-life improvement within 28 days · 4CYTE continues to provide improvement beyond Day 28 as levels build further · Results continue to improve with ongoing consistent use

  In a pilot study conducted at the University of Melbourne, 46 dogs with naturally occurring osteoarthritis received Epiitalis® Forte Gel for dogs and were assessed on Day 0 and Day 28 using two measurement tools: objective gait analysis with a GaitRite walkway system (measuring actual weight distribution as dogs walked) and the Helsinki Chronic Pain Index (11-question owner-reported quality-of-life assessment). At Day 28, 93.5% of dogs showed improvement in owner-reported quality-of-life scores. Objective gait analysis also showed measurable improvements in weight distribution on the study limb (the most severely affected limb). In the separate randomized controlled trial comparing 4CYTE Canine Granules to carprofen, improvement was documented at both Day 14 and Day 28, with the response pattern suggesting continued improvement between those two time points — meaning the product kept working rather than plateauing. Most dog owners notice the first visible signs of improvement — increased willingness to walk, less stiffness getting up in the morning, more enthusiasm for play — somewhere between Day 7 and Day 14. Full benefit from the complete loading phase is typically seen at 4–6 weeks.
• 6
  What are the ingredients in 4CYTE for dogs? Active ingredients (granule form, per scoop): Epiitalis® (patented plant seed oil extract from Biota orientalis) 22 mg · Green-lipped mussel (Perna canaliculus) + Abalone (Haliotis iris) + Marine cartilage — combined marine blend 278 mg · Inactive ingredients: Honey, molasses powder, nature-identical chicken flavour, sodium caseinate, tartaric acid

  4CYTE for dogs contains just four active ingredients — a notably clean and simple formulation compared to many joint supplements that include dozens of components. The central ingredient is Epiitalis® (22 mg per scoop in the granule form), extracted from the seed of the plant Biota orientalis. This is the globally patented, proprietary ingredient that distinguishes 4CYTE from all other supplements — no other product contains Epiitalis®. The marine blend (278 mg per scoop) consists of three complementary ingredients: green-lipped mussel from New Zealand (Perna canaliculus), which provides unique Omega-3 fatty acids including eicosatetraenoic acid (ETA); abalone (Haliotis iris), which contributes bioactive lipids and marine proteins; and marine cartilage sourced from non-endangered fish as a by-product of the food industry. These marine ingredients complement Epiitalis® by providing additional anti-inflammatory compounds, structural building blocks for cartilage, and naturally occurring joint-support compounds. All marine ingredients are ethically harvested and sustainably sourced under Australian and New Zealand regulations. The inactive ingredients — honey, molasses, chicken flavoring, sodium caseinate — contribute to palatability; most dogs accept 4CYTE without resistance when mixed into food. Sodium caseinate is a milk protein derivative; dogs with confirmed dairy protein allergies should be flagged with your veterinarian before use. Dogs with shellfish allergies (abalone is a shellfish) should also be monitored.
• 7
  Are there any side effects or risks with 4CYTE for dogs? Side effects are uncommon and generally mild · No known gastrointestinal, kidney, or liver risks with long-term use (unlike NSAIDs) · Most common reported issue: mild digestive adjustment during the first 3–7 days — reduced by starting at half the loading dose · Dogs with shellfish allergies (abalone is a shellfish) or dairy sensitivities (sodium caseinate, a milk protein) should be monitored · No known toxicity at recommended doses

  One of the most clinically significant advantages of 4CYTE over long-term NSAID therapy is its safety profile. NSAIDs (carprofen, meloxicam, deracoxib) are effective for pain relief but carry real risks with extended use: gastrointestinal ulcers, decreased kidney function, and potential liver enzyme elevation, which is why dogs on long-term NSAIDs require periodic blood monitoring. 4CYTE does not carry these risks — it has no known adverse effects on the gastrointestinal tract, kidneys, or liver at recommended doses, and is considered safe for indefinite long-term use. The most common adjustment-related issue is mild stomach upset or loose stools during the first few days of use, which is why the dosing protocol recommends starting at half the loading dose for the first three days. This typically resolves quickly. The ingredient abalone is a shellfish — dogs with documented shellfish allergies should be introduced to 4CYTE cautiously and monitored for signs of allergic reaction (facial swelling, hives, vomiting, difficulty breathing) during the first week. Sodium caseinate, derived from milk protein, may be relevant for dogs with confirmed dairy sensitivities. No drug interactions with 4CYTE have been identified in published research; it is used safely alongside carprofen, meloxicam, gabapentin, and other commonly prescribed canine medications in veterinary practice.
• 8
  Where can I buy 4CYTE for dogs in the United States? Available over the counter — no prescription required · In the USA: veterinary clinics, pet specialty stores (Petstock, independent pet stores), Amazon, Chewy, and the official website 4cyte.global · US distributor: Interpath USA Inc, 98 Cutter Rd Ste 466, Great Neck, NY 11021 · Comes as a liquid gel (Epiitalis Forte, 3.38 fl oz) or granules · Palatability guarantee — money back if your dog refuses it

  4CYTE is available without a veterinary prescription in the United States as an over-the-counter nutritional supplement. In the US, it is distributed by Interpath USA Inc, headquartered in Great Neck, New York. The product is available through veterinary clinics (some clinics stock it directly), pet specialty stores, online retailers including Amazon and Chewy, and directly from the official 4CYTE US website at 4cyte.global. The product comes in two forms for dogs: the liquid Epiitalis® Forte Gel (3.38 fl oz/100 mL) administered orally using the included syringe, and the Canine Granules mixed into food. For a 44-pound (20 kg) dog on maintenance dosing, a single 3.38 fl oz bottle lasts approximately 67 days. A 100g pouch of granules lasts approximately 120 days on maintenance dose for a medium dog (11–20 kg / 24–44 lbs). 4CYTE backs the product with a palatability guarantee — if your dog refuses to eat it, you receive a full refund. When purchasing through your veterinarian’s clinic, additional satisfaction guarantees may apply if expected results are not seen within the veterinarian-guided time frame. Verify current pricing and availability directly at 4cyte.global as prices vary by seller and product size.

⚠️ Dosing amounts above are general guidelines based on published product information. Always confirm the correct dose for your dog’s exact weight with your veterinarian. For the gel (Epiitalis Forte liquid), follow the volume markings on the supplied syringe applicator according to your dog’s weight. Introduce at half the loading dose for the first 3 days before starting full loading doses.

Use the buttons below to find a veterinarian, emergency animal hospital, or pet supply store carrying 4CYTE near your location. Always call ahead to confirm availability and hours.